Literature DB >> 9350695

Issues affecting the longevity of the continuous peritoneal dialysis therapy.

Y Kawaguchi1, T Hasegawa, M Nakayama, H Kubo, T Shigematu.   

Abstract

Continuous ambulatory peritoneal dialysis (CAPD) is one of the accepted dialysis modalities worldwide. However, the longevity of the CAPD technique and the patient survival associated with this modality have not been established. We review our 16 year experience in one treatment center in 224 patients who underwent CAPD. Overall, these patients survived on CAPD for a mean of 6.6 years; a 50% survival was reached at a mean of 5.5 years. Ultrafiltration loss was the most prominent cause of withdrawal from CAPD among patients in whom the technique was successful for more than 6 years. Countermeasures to decrease the CAPD-associated morbidity are crucial to prolonging the success of the technique, and thus increasing the duration of patient survival.

Entities:  

Mesh:

Year:  1997        PMID: 9350695

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  21 in total

1.  Increased lymphatic vessels in patients with encapsulating peritoneal sclerosis.

Authors:  Tatsuhiro Yaginuma; Izumi Yamamoto; Hiroyasu Yamamoto; Jun Mitome; Yudo Tanno; Keitaro Yokoyama; Takenori Hayashi; Tetsuya Kobayashi; Michiaki Watanabe; Yutaka Yamaguchi; Tatsuo Hosoya
Journal:  Perit Dial Int       Date:  2012-06-01       Impact factor: 1.756

2.  Can sonographic peritoneal thickness be used to follow pediatric patients on peritoneal dialysis?

Authors:  Aysun Caltik; Sare Gülfem Akyüz; Mehmet Bülbül; Gökçe Cinar; Ozlem Erdogan; Gülay Demircin
Journal:  Pediatr Nephrol       Date:  2013-01-09       Impact factor: 3.714

3.  Is the underutilization of peritoneal dialysis in relation to hemodialysis, as renal replacement therapy, justifiable worldwide? Yes or No.

Authors:  E Grapsa
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

Review 4.  Pathogenesis and treatment of peritoneal membrane failure.

Authors:  Ramesh Saxena
Journal:  Pediatr Nephrol       Date:  2007-09-21       Impact factor: 3.714

5.  In Peritoneal Dialysis, Is There Sufficient Evidence to Make "PD First" Therapy?

Authors:  Pranav Dalal; Harbaksh Sangha; Kunal Chaudhary
Journal:  Int J Nephrol       Date:  2011-06-16

Review 6.  Protective measures against ultrafiltration failure in peritoneal dialysis patients.

Authors:  Anna Rita Aguirre; Hugo Abensur
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Peritoneal Dialysis Drop-out: Causes and Prevention Strategies.

Authors:  Kunal Chaudhary
Journal:  Int J Nephrol       Date:  2011-10-27

8.  Treatment of severe ultrafiltration failure with nonglucose dialysis solutions in patients with and without peritoneal sclerosis.

Authors:  Watske Smit; Marja M Ho-Dac-Pannekeet; Raymond T Krediet
Journal:  NDT Plus       Date:  2008-10

9.  Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study.

Authors:  Bernard G Jaar; Laura C Plantinga; Deidra C Crews; Nancy E Fink; Nasser Hebah; Josef Coresh; Alan S Kliger; Neil R Powe
Journal:  BMC Nephrol       Date:  2009-02-06       Impact factor: 2.388

10.  Comparison of mesenchymal stromal cells from peritoneal dialysis effluent with those from umbilical cords: characteristics and therapeutic effects on chronic peritoneal dialysis in uremic rats.

Authors:  Yangchun Du; Ming Zong; Qiunong Guan; Zhongli Huang; Lan Zhou; Jing Cai; Gerald da Roza; Hao Wang; Hualin Qi; Yiping Lu; Caigan Du
Journal:  Stem Cell Res Ther       Date:  2021-07-13       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.